Baseline comorbidities in a skin cancer prevention trial in Bangladesh
Authors:
- 1 April 2013
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 43 (6) , 579-588
Abstract
Background: Epidemiologic research suggests that increased cancer risk due to chronic arsenic exposure persists for several decades even after the exposure has terminated. Observational studies suggest that antioxidants exert a protective effect on arsenical skin lesions and cancers among those chronically exposed to arsenic through drinking water. This study reports on the design, methods and baseline analyses from the Bangladesh Vitamin E and Selenium Trial (BEST), a population‐based chemoprevention study conducted among adults in Bangladesh with visible arsenic toxicity.Materials and methods: Bangladesh Vitamin E and Selenium Trial is a 2×2 full factorial, double‐blind, randomized controlled trial of 7000 adults having manifest arsenical skin lesions evaluating the efficacy of 6‐year supplementation with alpha‐tocopherol (100 mg daily) and L‐selenomethionine (200 μg daily) for the prevention of nonmelanoma skin cancer.Results: In cross‐sectional analyses, we observed significant associations of skin lesion severity with male gender (female prevalence odds ratio (POR) = 0·87; 95% CI = 0·79–0·96), older age (aged 36–45 years, POR = 1·27; 95% CI = 1·13–1·42; aged 46–55 years, POR = 1·44; 95% CI = 1·27–1·64 and aged 56–65 years, POR = 1·50; 95% CI = 1·26–1·78 compared with aged 25–35 years), hypertension (POR = 1·29; 95% CI = 1·08–1·55), diabetes (POR = 2·13; 95% CI = 1·32–3·46), asthma (POR = 1·55; 95% CI = 1·03–2·32) and peptic ulcer disease (POR = 1·20; 95% CI = 1·07–1·35).Conclusions: We report novel associations between arsenical skin lesions with several common chronic diseases. With the rapidly increasing burden of preventable cancers in developing countries, efficient and feasible chemoprevention study designs and approaches, such as employed in BEST, may prove both timely and potentially beneficial in conceiving cancer chemoprevention trials in Bangladesh and beyond.Keywords
This publication has 60 references indexed in Scilit:
- Inorganic Arsenic and Basal Cell Carcinoma in Areas of Hungary, Romania, and Slovakia: A Case–Control StudyEnvironmental Health Perspectives, 2012
- Arsenic Exposure and Hypertension: A Systematic ReviewEnvironmental Health Perspectives, 2012
- Creatinine, Diet, Micronutrients, and Arsenic Methylation in West Bengal, IndiaEnvironmental Health Perspectives, 2011
- Associations of Plasma Selenium with Arsenic and Genomic Methylation of Leukocyte DNA in BangladeshEnvironmental Health Perspectives, 2011
- Protective Effects of B Vitamins and Antioxidants on the Risk of Arsenic-Related Skin Lesions in BangladeshEnvironmental Health Perspectives, 2008
- Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesionsToxicology Letters, 2007
- A Prospective Study of Blood Selenium Levels and the Risk of Arsenic-Related Premalignant Skin LesionsCancer Epidemiology, Biomarkers & Prevention, 2007
- A review of the source, behaviour and distribution of arsenic in natural watersApplied Geochemistry, 2002
- Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radicalBiochemical and Biophysical Research Communications, 1990
- Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to AllergensNew England Journal of Medicine, 1989